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Abstract
OBJECTIVE: To assess the acute organ toxicity
of Strychnos nux-vomica with zebrafish model
visually.
METHODS: To assess acute toxicity, we initially de-
termined the lethal concentration after Strychnos
nux-vomica treatment for 24 h. Zebrafish was treat-
ed with five concentrations ≦ LC10 for 24 h, and
the effects of Strychnos nux-vomica on morpholo-
gy, function of heart, central nervous system, liver,
kidney and organ-specific cell death were assessed.
Next, we assessed the reversibility of toxic effect.
RESULTS: Strychnos nux-vomica has an effect on
the different organs of zebrafish, including heart,
central nervous system, liver, and kidney, and cadio-
toxicity induced by Strychnos nux-vomica was re-
versible to some extent.
CONCLUSION: Zebrafish model is suitable for con-
firming the toxic target organs for Chinese tradi-
tional medicine.
Key words: Zebrafish; Strychnos nux-vomica; Toxic-
ity
INTRODUCTION
Strychnos nux-vomica, in the family Loganiaceae, is
dry mature seeds of Strychnos nux-vomica Linn. It has
a long history as medicine and is widely used to treat
various diseases, including rheumatoid arthritis and ar-
thralgia. The Chinese Pharmacopoeia 2010 Edition re-
cords that it is warm, bitter and poisonous,1 distributed
to liver and spleen channels. It has the effect of treating
swelling, inflammation, exciting central nervous sys-
tem, and alleviating pain. However, its therapeutic use
is often hindered by problems such as its strong toxici-
ty.2 Therefore, it is important to strengthen the re-
search on the compatibility of Strychnos nux-vomica,
explore its effective compatibility, decrease its toxicity
and increase its efficacy.
Recently, it has widely proved that zebrafish is an inex-
pensive and alterative model for the rapid evaluation of
the potential toxicity for drug candidates since it shares
the physiological, morphological, and histological simi-
larities with mammals and human.3,4 The gene homolo-
gy between zebrafish and humans is as high as 85%. In
signal transduction pathways and at the protein level,
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the functional domains are highly conserved or struc-
turally identical.4,5 Compared with the traditional in vi-
vo model like mouse and in vitro cell culture model,
transparent zebrafish embryos offer unique advantages
for assessing the drug effects on various developmental
events because multiple organs can be observed under
the microscope.6 As a consequence, pharmacodynamic,
pharmacokinetic, and metabolite activities can be eval-
uated easily.7 In addition, low cost, short cycle, fewer
test compounds, and high throughput also make it a
promise and successfully used model in studying devel-
opmental toxicity,8 teratogenicity, cardiovascular toxici-
ty,9 liver toxicity,10 behavioral toxicity,11 kidney toxicity,12
and a series of evaluation assays.13,14
In this study, the acute toxicities and organ toxicity in-
duced by Strychnos nux-vomica was assessed in zebraf-
ish. The zebrafish model was found to be an alternative
or even better predictive toxicity model compared with
conventional system in Strychnos nux-vomica safety as-
sessment.
METHODS ANDMATERIALS
Zebrafish breeding and handling
Embryos were generated by natural pairwise mating as
described in The Zebrafish Book15 (Westerfield, 1993).
Embryos were maintained at 28.5 ℃ in fish water
(0.137 mol/L NaCl, 5.4 mmol/LKCl, 0.25 mmol/L
Na2HPO4, 0.44 mmol/L K2HPO4, 1.3 mmol/L CaCl2,
1.0 mmol/L MgSO4, and 4.2 mmol/L NaHCO3 (pH
7.0-7.2, conductivity 500-750 μs/cm)). Embryos were
cleaned (dead and unfertilized embryos removed) and
staged at 4 h post fertilization (hpf ). Because embryos
received nourishment from an attached yolk sac, no
feeding was required for 7 days post fertilization (dpf ).
Plant material and extraction
Strychnos nux-vomica was supplied blinded by the An-
guo Shengshan Pharmaceutical Co., Ltd., (Anguo, Chi-
na). Smashed into powders of 25.4 mm, the Strychnos
nux-vomica (50 g) was extracted with distilled water
ten-times volume of weight by refluxing for two h. Af-
ter the crude extract was ﬁ ltered, the supernatant was
collected for further procedure, and the residue was
successively extracted with distilled water ten-times vol-
ume of weight under reflux twice, once an hour. The
water extract was mixed, centrifuged (3000 × g) for
30 min (RJ-LDL-50G, Wuxi Ruijiang Analysis Instru-
ment Co., Ltd., Wuxi, China) and the supernatant was
concentrated under reduced pressure using a vacuum
rotary evaporator. After that, the water separation was
collected and dried under vacuum at room tempera-
ture. The dried extract was kept in a desiccator until it
was used. Prior to the following biological assays, the
whole extract was re-dissolved into the stock solution
(400 μg/mL) with fisher water, and then diluted to the
working concentrations.
Drug treatment
Different organs of zebrafish form at different stages.
To ensure comparability for assessing drug-induced le-
thality and acute toxicity, central nervous system
(CNS) and heart were assessed after treating 2 dpf ze-
brafish for 24 h, and liver and kidney were assessed af-
ter treating 4 dpf zebrafish for 24 h. For each concen-
tration, 20 zebrafish were distributed into 24-well
plates containing 2 mL sterile fish water, each well two
larva fish. During early embryogenesis, a protective
chorion membrane, which might interfere with com-
pound uptake, was present. Therefore, to facilitate
drug delivery, 2-dpf zebrafish were de-chlorinated us-
ing a 0.5 mg/mL of protease solution (P6911, Sig-
ma-Aldrich Co., St. Louis, MO, USA) for 15 min at
room temperature. 2-dpf or 4-dpf zebrafish were then
incubated with compounds for 24 h. For each experi-
ment, untreated zebrafish were used as assay control.
If > 10% of embryos in the untreated control group
were dead or malformed, the experiment was consid-
ered invalid and aborted.
Lethality assessment
To assess lethality, 10 concentrations were initially test-
ed: 0.01, 0.5, 0.1, 0.5, 1, 5, 10, 50, 100, and 400 μg/
mL. Based on the preliminary experiment, we set up
six concentrations at last. To establish lethality
curves, after treatment for 24 h, surviving zebrafish
exposed to different concentrations were counted,
and dead embryos were removed since dead zebrafish
can disintegrate, impeding counting. Experiments
were performed three times. LC50 and LC10 were cal-
culated using logistic regression analysis (SPSS Statis-
tics for Windows, Version 17.0., SPSS Inc., Chicago,
IL, USA).
Assessment of organ morphology / function toxicity
Six concentrations ≦ LC10, determined in lethality
studies, were used to assess organ-specific toxicity.
Drug treatment was performed as described above. Af-
ter heart rate and circulation were assessed, zebrafish
were anesthetized with 0.5 mm M3-aminobenzoic acid
ethyl ester (MESAB-22, Sigma-Aldrich Co., St. Louis,
MO, USA) and visually assessed using a
TE-2000-S-stereomicroscope (Nikon Chansn Instru-
ment Co., Ltd., Beijing, China) equipped with a
SPOT Insight digital camera. Three percent of methyl-
cellulose (Sigma-Aldrich Co., St. Louis, MO, USA)
was used to immobilize zebrafish to facilitate imaging.
For different organs, the end points for organ morphol-
ogy or function toxicity are different. Abnormal heart
rate, tachycardia, arrhythmia, abnormal circulation,
pericardial edema and abnormal heart chamber mor-
phology were used for evaluation standard of cardiac
toxicity, misshapen brain was for CNS toxicity, liver
size and color was for hepatotoxicity, and fluid accumu-
lation around the kidney, cyst formation, or trunk ede-
ma was for renal toxicity.
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Assessment of cell death after 24 h treatment
The same compound treatment strategy described in
section above was used for the cell death assays. At the
end point of the experiment, after washed by phos-
phate buffer saline (PBS) twice to remove excess drug,
zebrafish samples were stained with 1 μg/mL of acri-
dine orange (A8120, Sigma-Aldrich Co., St. Louis,
MO, USA) in the dark environment at 28.5℃ for 0.5 h,
followed which, the zebrafish, washed with PBS solu-
tion twice, were visually assessed by using a fluores-
cence microscope.
Assessment of reversibility of morphology / function
organ toxicity
To determine if the Strychnos nux-vomica-induced
acute toxicity was reversible, after treatment for 24 h,
the Strychnos nux-vomica was removed by washing
and the zebrafish were incubated in fresh fish water for
an additional 48 h. Finally, organ toxicitywas reassessed.
RESULT
LC10and LC50 determination
Two-dpf and four-dpf zebrafish were initially treated
for 24 h with different Strychnos nux-vomica concen-
trations ranging from 0.01 μg/mL to 400 μg/mL Tripli-
cate experiments were performed using 20 zebrafish
per concentrations. On the basic of the results of pre-
liminary experiment, no lethality was detected at con-
centrations of 10 μg/mL, and 400 μg/mL could lead
all 2-dpf zebrafish to die, while the death was rare in
the condition of 100 μg/mL. The additional concentra-
tions, including 50, 100, 150, 200, 250, 300, 350, and
400 μg/mL, were then assessed in two experiments.
For the 4-dpf zebrafish, 100% lethality was detected at
concentration of 100 μg/mL, and no lethality was de-
tected up to concentration of 5 μg/mL. Finally six ex-
perimental concentrations for the LC10 and LC50 deter-
mination was determined for cardiac toxicity and CNS
toxicity of 2-dpf zebrafish, including 5, 10, 50, 100,
150, and 200 μg/mL, while 5, 10, 25, 50, 75, and 100 μg/
mL for hepatotoxicity and renal toxicity of 4-dpf ze-
brafish. 2dpf zebrafish lethality curves are presented in
Figure 1A and 4dpf zebrafish in Figure 1B. Based on
the zebrafish lethality curves of the acute toxicity as-
says, LC10 of Strychnos nux-vomica for 2-dpf or 4-dpf
zebrafish was calculated, and the results are 22.2 μg/
mL and 7.2 μg/mL, respectively.
To assess the organ toxicity, five concentrations ≦
LC10 selected for heart and CNS were 1, 5, 10, 15,
20 μg/mL, for liver and kidney 1, 2, 3, 4, 5 μg/mL,
respectively.
Organ toxicity after treatment for 24 h
Organ morphology and function were assessed after
Strychnos nux-vomica treatment for 24 h at 2-dpf or
4-dpf stage. For each experiment, in addition to com-
pound-treated zebrafish, untreated zebrafish were as-
sessed concurrently. Results for assessing toxic effects
on heart rate were recorded at four h post-treatment
and 8 h post-treatment, and were analyzed for statisti-
cal significance (Table 1). All data between 4 h and 8 h
post-treatment were analyzed by paired-sample to com-
pare the comprehensive evaluation values, and the re-
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Figure 1 Strychnos nux-vomica induced zebrafish death rate at 2 dpf or 4dpf stage
A: 2dpf zebrafsh mortality rate; B: 4dpf zebrafish mortality.
B
Table 1 Effect of Strychnos nux-vomica on heart rate in 10 s
of zebrafish embryos ( xˉ ± s)
Concentration
(μg/mL)
0
5
10
50
100
150
200
Heart rate (beats/10 s)
4 h
40.3±0.7
40.0±0.8
40.2±0.6
35.7±0.7ab
33.0±0.8ab
24.0±14.4ab
14.5±11.9ab
8 h
40.2±0.6
40.2±0.6
40.3±0.7
33.3±0.7ab
28.5±1.5ab
16.8±12.2ab
-
Notes: heart rate changes in 2dpf zebrafish versus untreated
2dpf zebrafish after 24 h of treatment after 24 h of treatment.
Each point represents mean + standard error of the mean from a
representative experiment. n = 6, aP < 0.01, compared with 0 μg/
mL of Strychnos nux-vomica at the different treated time; bP <
0.01. Since at the 8 h post-treatment, there was lethal in the con-
centration of 200 μg/mL, so the heart rate was not assessed.
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sults showed that there was a significant difference in
heart rate in 10 s of zebrafish embryos between before
Strychnos nux-vomica treatment and after treatment
with the concentration ≧ 50 μg/mL (P < 0.01). The
results proved that the heart rate was significantly de-
creased by Strychnos nux-vomica exposure in a
dose-dependent manner. At the five concentrations ≦
LC10, there was no significant difference in effect on
heart rate between Strychnos nux-vomica treatment
group and the control group.
Results showed that Strychnos nux-vomica caused tox-
icity in all four organs: heart, CNS, liver, and kidney.
Except reduced heart rate, pericardial edema in heart was
also observed. Tissue discoloration was observed in the
brain, indicating there was degeneration (Figure 2).
Discolored liver and retained yolk was observed (Figure
3). Trunk edema indicated potential defective kidney
function was observed at the high concentrations but
not at the concentrations≦ LC10.
Cell death assessed after 24 h treatment
After using the same treatment conditions for visually
assessing organ toxicity, we assessed the cell death. Two
or four-dpf zebrafish were treated with Strychnos
nux-vomica for 24 h, and cell death in heart, CNS, liv-
er, and kidney was assessed. Compound-induced cell
death in each organ was assessed visually by staining
with fluorescent acridine orange, and the results are
shown. After exposed to Strychnos nux-vomica, cell
death was observed in heart and CNS (Figure 4), as
well as liver and kidney (Figure 5). Compared with the
control group that there were only a few apoptotic cells
existing, the number of apoptotic cells in the heart,
CNS, kidney and liver in the treated group increased
in a concentration-dependent manner.
Evaluation of reversibility of toxicity 48 h after
strychnos nux-vomica removal
In order to evaluate if Strychnos nux-vomica-induced
acute toxicity was reversible, after treatment for 24 h,
zebrafish were washed in fresh fish water to remove
Strychnos nux-vomica and incubated for an additional
48 h, and organ morphology and function were then
reassessed visually in the surviving animals. Although
heart rate in the treatment group at the five concentra-
tions ≦ LC10 was not significantly different with that
in the control group, the presented pericardium edema
was significantly improved (Figure 6). Besides, the
heart rate of surviving animals at the concentrations of
50 and 25 μg/mL was also significantly improved. For
the liver and kidney, while discolored liver, retained
yolk, trunk edema was significantly improved (Figure
7), but it still existed, and the cell death assessment
showed that cell death was observed in liver and kid-
ney. These results indicate that the heart toxicity in-
duced by Strychnos nux-vomica is reversible.
DISCUSSION
Most zebrafish assays rely on aqueous exposure and its
size, low cost, fecundity, rapid development of most or-
gans within 48 hpf, capacity to absorb low molecular
weight compounds which dissolved in the culture wa-
ter through their chorion, skin, and gills, making it
suit for small molecule screening, especially for
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Figure 2 Effect of Strychnos nux-vomica on morphology of heart and central nervous system of zebrafish at 72 hpf (× 10)
2dpf zebrafish were treated with different concentrations strychnos nux-vomica for 24 h. A: normal group; B: strychnos nux-vomi-
ca 1 μg/mL group; C: sStrychnos nux-vomica 5 μg/mL group; D: strychnos nux-vomica 10 μg/mL group; E: strychnos nux-vomica
15 μg/mL group; F: strychnos nux-vomica 20 μg/mL group. White arrows indicate pericardium edema and red arrows indicate
misshapen brain. Strychnos nux-vomica caused central nervous system toxicity and heart toxicity in a dose-dependent manner.
Zhao CJ et al. / Experimental Study
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Figure 3 Effect of Strychnos nux-vomica on morphology of liver and kidney of zebrafish at 5-dpf (× 10)
4 dpf zebrafish were treated with different concentrations Strychnos nux-vomica for 24 h. A: normal group; B: Strychnos nux-vom-
ica 1 μg/mL group; C: Strychnos nux-vomica 5 μg/mL group; D: Strychnos nux-vomica 10 μg/mL group; E: Strychnos nux-vomica
15 μg/mL group; F: Strychnos nux-vomica 20 μg/mL group. Arrows indicate retained yolk, the size of which is increased in a
dose-dependent manner. Strychnos nux-vomica caused liver toxicity and kidey toxicity in a dose-dependent manner.
Zhao CJ et al. / Experimental Study
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Figure 4 Cell death assessed in heart and central nervous system in 3-dpf zebrafish at the concentrations (× 10)
3dpf zebrafish treatedwithdifferent concentrationsStrychnosnux-vomica for24hwere stainedbyacridineorange.A:normalgroup;
B: Strychnos nux-vomica 1 μg/mL group; C: Strychnos nux-vomica 5 μg/mL group; D: Strychnos nux-vomica 10 μg/mL group; E:
Strychnos nux-vomica 15 μg/mL group; F: Strychnos nux-vomica 20 μg/mL group. Autofluorescence, particularly in the heart and
CNS,wasobservedduringexposure fluorescence lightWhitearrowsshowcelldeath in theheart and redarrowsshowcelldeath in the
CNS.Withtheconcentration increased, thedensityandareaof fluorescent inheartandCNSis increased.CNS:central nervous system.
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Figure 5 Cell death assessed in kidney and liver in 5-dpf zebrafish at the concentrations (× 10)
5 dpf zebrafish treated with different concentrations Strychnos nux-vomica for 24 h were stained by acridine orange. A: normal
group; B: Strychnos nux-vomica 1 μg/mL group; C: Strychnos nux-vomica 5 μg/mL group; D: Strychnos nux-vomica 10 μg/mL
group; E: Strychnos nux-vomica 15 μg/mL group; F: Strychnos nux-vomica 20 μg/mL group. Autofluorescence, particularly in the
liver and kidney, was observed during exposure fluorescence light White arrows show cell death in the liver and red arrows show
cell death in the kidney.With the concentration increased, the density and area of fluorescent in liver and kidney is increased.
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Figure 6 Reversibility of toxicity assessed in heart and central nervous system in 5-dpf zebrafish at the different concentrations (×
10)
3 dpf zebrafish treated with different concentrations Strychnos nux-vomica for 24 h were cultured in the fresh water for 48 h. A:
normal group; B: Strychnos nux-vomica 1 μg/mL group; C: Strychnos nux-vomica 5 μg/mL group; D: Strychnos nux-vomica 10 μg/
mL group; E: Strychnos nux-vomica 15 μg/mL group; F: Strychnos nux-vomica 20 μg/mL group. White arrows show reversibility in
the heart and red arrows showed reversibility in the CNS. 48 h after removing, the pericardium edema in heart and misshapen
brain with dark brown was significantly improved in a dose-dependent manner. CNS:central nervous system.
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high-throughput screening since the analysis of the ef-
fects of compounds in zebra-fish larvae requiring lower
compound.16,17
In the acute toxicity assays, Strychnos nux-vomica
showed large variation in their acute toxicity to the
heart, brain, liver and kidney, and the Strychnos
nux-vomica had the lower LC50 value (102.2 μg/mL)
for former while Strychnos nux-vomica had the higher
LC50 value(47.2 μg/mL) for later. Also, acute toxicity of
zebrafish also showed that zebrafish have strong sensi-
tivity to toxicity since low concentration of Strychnos
nux-vomica can cause adverse effects of the heart, kid-
ney, liver and CNS of zebrafish. It has a good correla-
tion with other mammalian models which belongs to
the liver meridian. Also, the result showed that low
concentration can cause changes in the phenotype of
heart, while the high concentrations can cause the
heart functional deficit.
In the experiment of evaluation of reversibility of toxic-
ity, CNS and heart toxicity were observed after 24 h
treatment, but those toxicity were significantly im-
proved 48 h after Strychnos nux-vomica compound
was removed, indicating the organ toxicity was revers-
ible. Cell death was observed in liver and kidney after
24 h treatments, and cell death in these organs was still
found 48 h after compound removed, which indicate
that there is the delayed toxicity.
Despite all of these, however, for Strychnos nux-vomi-
ca, there are still lots of problems in theory and experi-
ment method, such as lack of a complete experimental
operating standard and organism toxicity phenotypic
evaluation standards, as well as sufficient data to com-
pared results in zebrafish with results in mammalian
models. The ultimate goal of toxicity experiment is to
determine the concentration with which no observable
toxicity in induced. In the future studies, we hope that
the toxicity of Strychnos nux-vomica on any of the
four organs (heart, brain, liver, or kidney) of zebrafish
would be counted and expressed as percent incidence
for each condition. Percent incidence and concentra-
tion would be then correlated, and no observed effect
concentration would be estimated for Strychnos
nux-vomica.
Certainly, the research of this thesis is only a prelimi-
nary attempt to probe the applicability of the zebrafish
model in the toxicity studies of toxic Chinese tradition-
al medicine. Furthermore, it is necessary to make full
use of the advantages of the zebrafish to provide a basis
for the studies of toxic Chinese medicine toxicity in
the future. In conclusion, zebrafish model has become
a valuable tool for assessing and predicting Traditional
Chinese Medicine toxicity.
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